Inventor

Jeffrey E. Kropf

Inventor
Branford, CT, US

Overview

34→
Patents
2010–2021
Patent span
Human necessities
Primary field (CPC A)

Patents· 34 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations28%
C07DHeterocyclic compounds28%
A61KPreparations for medical, dental or toiletry purposes22%
C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms6%
G01NInvestigating or analysing materials by determining their chemical or physical properties6%
C07CAcyclic or carbocyclic compounds5%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium5%
PatentTitleYear
11,116,760Quinoline derivatives202110,842,803Imidazopyridines Syk inhibitors202010,828,299Crystalline monomesylate salt of 6-(6-aminopyrazin-2-yl)-n-(4-(4-(oxetan-3-yl)piperazin-1-yl)phenyl)imidazo[1,2-a]pyrazin-8-amine202010,774,054FXR (NR1H4) modulating compounds202010,421,730FXR (NR1H4) modulating compounds201910,344,040Pyridone and aza-pyridone compounds and methods of use201910,342,794Substituted imidazo[1,2-a]pyrazines as Syk inhibitors201910,329,286FXR (NR1H4) modulating compounds201910,093,684Substituted imidazo[1,2-a]pyrazines as Syk inhibitors201810,092,583Imidazopyridines Syk inhibitors201810,053,469Pyridone and aza-pyridone compounds and methods of use201810,005,774Syk inhibitors20189,968,601Substituted imidazo[1,2-a]pyrazines as Syk inhibitors20189,938,278FXR (NR1H4) modulating compounds20189,931,338Syk inhibitors20189,796,718'6-(benzo[d]thiazol-5-yl)-n-(3,4-dimethoxyphenyl)imidazo[1,2-a]pyrazin-8-amine'20179,567,348'Substituted pyrazolo[1,5-a]pyrimidines as Syk inhibitors'20179,562,056'Imidazopyridines Syk inhibitors'20179,504,684'Syk inhibitors'20169,505,785'Pyridone and aza-pyridone compounds and methods of use'20169,376,441'Substituted pyrrolidines as SYK inhibitors'20169,290,505'Substituted imidazo[1,2-a]pyrazines as Syk inhibitors'20168,962,835'Imidazopyrazine Syk inhibitors'20158,748,607'Imidazopyrizine syk inhibitors'20148,618,107'Pyridone and aza-pyridone compounds and methods of use'20138,598,174'Pyridazinones, method of making, and method of use thereof'20138,455,493'Imidazopyrazine Syk inhibitors'20138,440,667'Imidazopyrazine Syk inhibitors'20138,426,424'Certain substituted amides, method of making, and method of use thereof'20138,247,550'Certain substituted amides, method of making, and method of use thereof'20128,058,446'Certain substituted amides, method of making, and method of use thereof'20117,947,835'Certain substituted amides, method of making, and method of use thereof'20117,884,108'Certain substituted pyrazinones'20117,838,523'Certain substituted amides, method of making, and method of use thereof'2010

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2010–2019Based in Branford, CT, US· patent location history
2011–2019Patents assigned to GILEAD CONNECTICUT INC (16)· patent assignee history
2011–2017Patents assigned to BLOMGREN PETER A (8)· patent assignee history
2011–2017Patents assigned to CURRIE KEVIN S (8)· patent assignee history
2011–2017Patents assigned to KROPF JEFFREY E (8)· patent assignee history
2016–2021Patents assigned to GILEAD SCIENCES INC (13)· patent assignee history
2017–2021Based in Issaquah, WA, US· patent location history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
GILEAD CONNECTICUT INC162011–2019
GILEAD SCIENCES INC132016–2021
BLOMGREN PETER A82011–2017
CURRIE KEVIN S82011–2017
KROPF JEFFREY Eself82011–2017
Locations
LocationPatentsSpan
Branford, CT, US202010–2019
Issaquah, Washington, US142017–2021